Role of mitotane in the management of adrenal cortex carcinoma;Place du mitotane dans la prise en charge du carcinome corticosurré nalien

Actualites Pharmaceutiques Hospitalieres

Volumn 7, Issue 25, 2011, Pages 39-41

  Attivi, David ^a   Gibaud, Stéphane ^a  

^a Centre Hospitalier de Neufchâteau 88   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MITOTANE;

ADRENAL CORTEX CARCINOMA; ARTICLE;

EID: 79960525593     PISSN: 17697344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1769-7344(11)70336-5     Document Type: Article

References (22)

1. S. Nader, R.C. Hickey, R.V. Sellin, and N.A. Samaan Adrenal cortical carcinoma. A study of 77 cases Cancer 52 4 1983 707 711 (Pubitemid 13025928)
2. B.L. Wajchenberg, M.A. Albergaria Pereira, and B.B. Medonca Adrenocortical carcinoma: clinical and laboratory observations Cancer 88 4 2000 711 736 (Pubitemid 30091090)
3. A.P. Dackiw, J.E. Lee, R.F. Gagel, and D.B. Evans Adrenal cortical carcinoma World J Surg 25 7 2001 914 926 Review (Pubitemid 32666394)
4. B. Allolio, and M. Fassnacht Clinical review: Adrenocortical carcinoma: clinical update J Clin Endocrinol Metab 91 6 2006 2027 2037 (Pubitemid 43854976)
5. R.F. Pommier, and M.F. Brennan An eleven-year experience with adrenocortical carcinoma Surgery 112 6 1992 963 970 discussion 970-1
6. A. Stojadinovic, R.A. Ghossein, and A. Hoos Adrenocortical carcinoma: clinical, morphologic, and molecular characterization J Clin Oncol 20 4 2002 941 950 (Pubitemid 34141836)
7. A.A. Nelson, and G. Woodard Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(parachlorophenyl)-1,1- dichloroethane (DDD or TDE) Arch Pathol (Chic) 48 5 1949 387 394
8. J. Nichols, and G. Hennigar Studies on DDD, 2,2-bis (parachlorophenyl)-1, 1-dichloroethane Exp Med Surg 15 4 1957 310 316
9. P.J. Trainer, and M. Besser Cushing's syndrome. Therapy directed at the adrenal glands Endocrinol Metab Clin North Am 23 3 1994 571 584 Review (Pubitemid 24300127)
10. H. Ahlman, A. Khorram-Manesh, and S. Jansson Cytotoxic treatment of adrenocortical carcinoma World J Surg 25 7 2001 927 933 (Pubitemid 32666395)
11. E.Z. Wallace, J.N. Silverstein, L.S. Villadolid, and S. Weisenfeld Cushing's syndrome due to adrenocortical hyperplasia. Treatment with an inhibitor of adrenocortical secretions N Engl J Med 265 1961 1088 1093
12. A.M. Hutter Jr. , and D.E. Kayhoe Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients Am J Med 41 4 1966 581 592
13. H. Slooten, A.J. Moolenaar, A.P. van Seters, and D. Smeenk The treatment of adrenocortical carcinoma with o,p'-DDD: prognostic implications of serum level monitoring Eur J Cancer Clin Oncol 20 1 1984 47 53 (Pubitemid 14224356)
14. E. Baudin, G. Pellegriti, and M. Bonnay Impact of monitoring plasma 1,1-dichlorodiphenildichloroethane (o,p'DDD) levels on the treatment of patients with adrenocortical carcinoma Cancer 92 6 2001 1385 1392 (Pubitemid 32947821)
15. M. Terzolo, A. Pia, and A. Berruti Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer J Clin Endocrinol Metab 85 6 2000 2234 2238 (Pubitemid 32269248)
16. G. Dickstein, C. Shechner, and E. Arad Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma? J Clin Endocrinol Metab 83 9 1998 3100 3103 (Pubitemid 28500941)
17. A.A. Kasperlik-Zaluska Clinical results of the use of mitotane for adrenocortical carcinoma Braz J Med Biol Res 33 10 2000 1191 1196
18. R. Vassilopoulou-Sellin, V.F. Guinee, and M.J. Klein Impact of adjuvant mitotane on the clinical course of patients with adrenocortical cancer Cancer 71 10 1993 3119 3123 (Pubitemid 23145548)
19. G. Dickstein, C. Shechner, and E. Arad Is there a role for low doses of mitotane (o,p'-DDD) as adjuvant therapy in adrenocortical carcinoma? Comment in: J Clin Endocrinol Metab 84 4 1999 1488 1489 (Pubitemid 30644424)
20. M. Terzolo, A. Angeli, and M. Fassnacht Adjuvant mitotane treatment for adrenocortical carcinoma N Engl J Med 356 23 2007 2372 2380 (Pubitemid 46883771)
21. A. Berruti, M. Terzolo, and P. Sperone Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial Endocr Relat Cancer 12 3 2005 657 666 (Pubitemid 41482999)
22. D. Attivi, I. Ajana, and A. Astier Development of microemulsion of mitotane for improvement of oral bioavailability Drug Dev Ind Pharm 36 4 2010 421 427